Tirzepatide - Eli Lilly and Company
At a glance
- Drug Originator Eli Lilly and Company
- Drug Licenced by Aspen Pharmacare Australia
- Drug Class Antihyperglycaemics; Antipsoriatics; Antirheumatics; Glucagon-like peptides; Heart failure therapies; Hepatoprotectants; Obesity therapies; Sleep disorder therapies
- Mechanism of Action Gastric inhibitory polypeptide receptor agonists; Glucagon-like peptide-1 receptor agonists
- USA Patent Applicants ELI LILLY AND CO
- USA Patents 5
- NDAs 2
- International Patents 117
Table of Contents

Disclaimer